NEW YORK, United States, Oct. 06, 2022 (GLOBE NEWSWIRE) -- According to Facts and Factors has published a new research report titled “ADME Toxicology Testing Market By Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Other Toxicities), By Method (Cellular Assay, Biochemical Assay, In-Silica, and Ex-Vivo), and By End-User (Cosmetics & Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2020 – 2026” in its research database.
“According to the latest research study, the of global ADME Toxicology Testing Market size was valued at USD 5.4 billion in 2020 and it is expected to surpass around USD 11.49 billion mark by 2026, growing at a compound annual growth rate (CAGR) of approximately 11.4% during the forecast period 2021 to 2026.”
ADME Toxicology Testing Market Overview:
In clinical trials on causes and systemic reactions like medicinal, chemical, and genetic reactions, ADME (absorption, distribution, metabolism, and excretion) toxicology testing is used to assess toxic reactions caused by molecules. This toxicology research techniques aid in the manufacture of successful drugs by limiting or preventing toxic reactions in the body. Toxicity thresholds are determined based on the outcomes of a series of experiments carried out in close to natural environments, which reflect almost real-time interactions between the agent and the host.
The demand for new medicines and biological products is increasing as disease incidence rises. This is one of the major reasons behind the use of ADME toxicology tests to avoid candidate drug failure in late-stage clinical trials. In addition, one of the major industry developments is the Food and Drug Administration's (FDA) launch of multiple guidance manuals that offer instruction on ADME properties when assessing the safety and effectiveness of a drug candidate. Apart from that, program that calculates ADME automatically is gaining popularity as an alternative to traditional in vitro and in vivo studies.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/adme-toxicology-testing-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2021 updated report.
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2021
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
Market Dynamics
The major drivers for the global ADME toxicology testing market is an increase in the number of drug developments, as well as increased demand from several biotechnology and pharmaceutical companies across the world. Because of reduced prices associated with multiple studies during the drug discovery period, faster time to market for new products and a reduction in the number of drugs fails that happened before, the number of drug failures has decreased. As a result, technical advances such as the use of in silico techniques, which use computer-based analytical methods for faster results, would fuel future demand.
Modern cell-based assays are gaining widespread recognition and will continue to propel this demand in the future. To gain a larger share of the market, companies are now focusing on partnerships, developing new solutions, and improving their products. Growing interest among researchers in ADME toxicology testing due to technological advances. The number of clinical trials being conducted around the world is increasing due to rising healthcare expenditure. Health investment in the rest of the global economy is rising at a significant pace per year, according to the World Health Organization (WHO).
Healthcare spending in low- and middle-income countries is increasing at a rate of about 6% per year, compared to 4% in developing countries. Governments around the world are providing an estimate of about 51% of a company's health budget. As a result of the growth in health-care costs, demand for ADME toxicology testing will rise over the projected period.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/adme-toxicology-testing-market
Segmentation Analysis
The ADME toxicology testing market is segmented as a technology, application, method, end-user, and region.
By technology segment, the market is segmented into high throughput, OMICS technology, cell culture, and molecular imaging. By application segment, the market is segmented into renal toxicity, systemic toxicity, neurotoxicity, hepatotoxicity, and other toxicities. By method segment, the market is segmented into biochemical assay, cellular assay, ex-vivo, and in-silica.
By end-user segment, the market is segmented into pharmaceutical industry, cosmetics & household products, food industry, animal industry, and others. Geographically, the global ADME toxicology testing market is divided into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.
The global ADME Toxicology Testing market is segmented as follows:
By Technology
- Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
By Application
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Other Toxicities
By Method
- Cellular Assay
- Biochemical Assay
- In-Silica
- Ex-Vivo
By End-User
- Cosmetics & Household Products
- Pharmaceutical Industry
- Animal Industry
- Food Industry
- Others
Browse the full “ADME Toxicology Testing Market By Technology (Cell Culture, High Throughput, Molecular Imaging, and OMICS Technology), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, and Other Toxicities), By Method (Cellular Assay, Biochemical Assay, In-Silica, and Ex-Vivo), and By End-User (Cosmetics & Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, and Others): Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2020 – 2026” Report at https://www.fnfresearch.com/adme-toxicology-testing-market
Competitive Landscape
The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards. Some of the main competitors dominating the global ADME Toxicology Testing market include -
- Thermo Fisher Scientific Inc
- Promega Corporation
- Beckman Coulter Inc
- (Danaher)
- Albany Molecular Research Inc
- Eurofins Scientific SE
- Life Technologies Corporation
- Quintiles
- Agilent Technologies
- Accelrys Inc
- (Dassault Systemes BIOVIA)
- Catalent
- Covance Inc. (LabCorp)
- Charles River Laboratories International Inc
- General Electric Company (Healthcare)
- MiltenyiBiotec
Key Insights from Primary Research:
- According to the analysis shared by our research forecaster, the ADME Toxicology Testingmarket is likely to expand at a CAGR of around 11.4% during the forecast period (2021-2026).
- In terms of revenue, the ADME Toxicology Testing market size was valued at around US$ 5.4 Billion in 2020 and is projected to reach US$ 11.4 Billion by 2026.
- Based on technology, the cell culture category in technology segmentation dominated the technology segmentation in 2019 with market share of around 40% and is expected to continue its dominance in upcoming years.
- Based on the application, the systemic toxicity category in application segmentation dominated the application segmentation in 2019 with market share of around 70% and is expected to continue its dominance in upcoming years.
- North America region dominated the global ADME toxicology testing market in 2019 with a market share of around 45% and is anticipated to continue its dominance in the forecast period.
Key Offerings:
- Market Size & Forecast by Revenue | 2021−2026
- Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
- Market Segmentation – A detailed analysis by Technology, Application, Method, End-User, and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/adme-toxicology-testing-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis:
In terms of geography, North America was the leading market share the global ADME toxicology testing market followed by Europe in 2019. North America is expected to dominate the growth of ADME toxicology testing due to the easy accessibility of diagnosis, and technical advances in the medical industry. The United States has the highest market share. In developed countries, the United States has a one-of-a-kind healthcare infrastructure.
North America accounted leading market share of the market, with throughput/content filtering emerging as a significant contributor. This is due to continuous technical advances in the area, particularly in the United States. Drug research methods based on cell cultures have become increasingly common with businesses attempting to bring a new drug molecule to market. Due to expanded efforts for new medicinal molecules and the introduction of newer technology to raise the quality of medication being supplied,
Asia Pacific is expected to rise at a substantial rate over the forecast years. China and Japan are important contributors to business expansion.
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Report Scope
| Report Attribute | Details |
| Market Size in 2020 | USD 5.4 Billion |
| Projected Market Size in 2026 | USD 11.49 Billion |
| CAGR Growth Rate | 11.4% CAGR |
| Base Year | 2020 |
| Forecast Years | 2020-2026 |
| Key Market Players | Thermo Fisher Scientific Inc., Promega Corporation, Beckman Coulter Inc., (Danaher), Albany Molecular Research Inc., Eurofins Scientific SE, Life Technologies Corporation, Quintiles, Agilent Technologies, Accelrys Inc., (Dassault Systemes BIOVIA), Catalent, Covance Inc. (LabCorp), Charles River Laboratories International Inc., General Electric Company (Healthcare), MiltenyiBiotec among others. |
| Key Segment | By Technology, Application, Method, End-User, and Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. |
Browse Other Related Research Reports from Facts & Factors:
Global Cell and Gene Therapy Consumables Market Share is Likely to Grow at a CAGR Value of 18.50% By 2026: https://www.fnfresearch.com/cell-and-gene-therapy-consumables-market
Global Agrigenomics Market Projected to Grow and Reach USD 19.37 Billion by 2026: https://www.fnfresearch.com/agrigenomics-market
Global 3D Cell Culture Market Projected to Reach USD 2.92 Billion by 2026: https://www.fnfresearch.com/3d-cell-culture-market
Global Biologics Safety Testing Market Projected to Reach USD 6.83 Billion by 2026: https://www.fnfresearch.com/biologics-safety-testing-market-by-product-services-instruments-946
Global Oligonucleotide Market Revenue Is Projected Around USD 14.6 Billion by 2026: https://www.fnfresearch.com/oligonucleotide-market-by-offering-equipment-reagents-consumables-and-151
Global RNAi for Therapeutics Market Revenue Projected Around USD 2,493.73 Million by 2026: https://www.fnfresearch.com/rnai-for-the-therapeutics-market-by-type-sirna
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Contact Us:
Facts & Factors
USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999
Email: sales@fnfresearch.com | Web: https://www.fnfresearch.com
Follow Us on - LinkedIn | Twitter | Facebook
